Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis.

JAAD Case Rep

Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.

Published: October 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519267PMC
http://dx.doi.org/10.1016/j.jdcr.2020.08.017DOI Listing

Publication Analysis

Top Keywords

percent lovastatin
4
lovastatin ointment
4
ointment pathogenesis-directed
4
pathogenesis-directed monotherapy
4
monotherapy porokeratosis
4
percent
1
ointment
1
pathogenesis-directed
1
monotherapy
1
porokeratosis
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!